SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0000950170-24-049935
Filing Date
2024-04-29
Accepted
2024-04-29 16:30:13
Documents
6
Period of Report
2024-06-11

Document Format Files

Seq Description Document Type Size
1 DEF 14A lctx_proxy_2024.htm DEF 14A 889687
2 GRAPHIC img30298293_0.jpg GRAPHIC 5342
3 GRAPHIC img30298293_1.jpg GRAPHIC 197120
4 GRAPHIC img30298293_2.jpg GRAPHIC 144550
5 GRAPHIC img30298293_3.jpg GRAPHIC 1369480
6 GRAPHIC img30298293_4.jpg GRAPHIC 165984
  Complete submission text file 0000950170-24-049935.txt   3481733
Mailing Address 2173 SALK AVENUE SUITE 200 CARLSBAD CA 92008
Business Address 2173 SALK AVENUE SUITE 200 CARLSBAD CA 92008 5105213390
Lineage Cell Therapeutics, Inc. (Filer) CIK: 0000876343 (see all company filings)

IRS No.: 943127919 | State of Incorp.: CA | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-12830 | Film No.: 24891427
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)